1887

Olopatadine hydrochloride

This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition
  1. Gonzalez-Estrada A, Reddy K, Dimov V and Eidelman F (2017) Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.Expert Opinion on Pharmacotherapy 18, 1137–1143
  2. Iwamoto K, Ikeda J, Nito M et al. (2001) Effect of olopatadine hydrochloride, a novel antiallergic agent, on the QT interval in dogs.Nihon Yakurigaku Zasshi 117, 401–409
  3. Kam KW, Chen LJ, Wat N and Young AL (2017) Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis.Ocular Immunology and Inflammation 25, 663–677
  4. Ohmori K, Hasegawa K, Tamura T et al. (2004) Properties of olopatadine hydrochloride, a new antiallergic/antihistaminic drug.Arzneimittelforschung 54, 809–829
  5. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health (2016)Olopatadine for the Treatment of Allergic Conjunctivitis: A Review of the Clinical Efficacy, Safety, and Cost-Effectiveness. Available from: www.ncbi.nlm.nih.gov/books
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error